NLRC5 is a major regulator of the expression of the MHC-I gene complex, including HLA-A, HLA-B, HLA-C, β2m, LMP2, LMP7 and TAP1, which are necessary for the presentation of neoantigens to CD8+ T cells resulting in the elimination of cancer cells [521]. Here, NLRC5 is linked to cancer.